Skip to main content

Featured

Questrade Just Went "Agentic" — What It Means For Your Trading Account

Published July 30, 2026 If you have money sitting in a Questrade account, the platform you log into is about to change more than it has in years. On July 30, Questrade unveiled its biggest product push since it eliminated stock trading commissions in 2019 — and this time, the headline feature isn't a lower fee. It's letting an AI assistant place trades for you. Questrade now manages roughly $100 billion in client assets, up from about $9 billion in 2019, and it's using that scale to go after Canada's increasingly crowded self-directed investing market. Here's what actually launched, and what it means before you touch any of it. What's actually new AI assistants can now trade on your behalf. Questrade is the first Canadian financial institution to officially connect client accounts directly to AI assistants like Claude and ChatGPT through something it calls Questrade MCP. In practice, that means you can ask an AI to pull up your account information, research a s...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment